vs
DYNAVAX TECHNOLOGIES CORP（DVAX）与RMR GROUP INC.（RMR）财务数据对比。点击上方公司名可切换其他公司
DYNAVAX TECHNOLOGIES CORP的季度营收约是RMR GROUP INC.的1.4倍（$94.9M vs $66.7M），DYNAVAX TECHNOLOGIES CORP净利率更高（28.4% vs 18.3%，领先10.1%），RMR GROUP INC.同比增速更快（40.8% vs 17.7%）
Dynavax Technologies Corp是一家处于商业化阶段的生物制药企业，专注于研发和生产针对传染病的创新疫苗及免疫疗法，核心上市产品为成人乙肝疫苗Heplisav-B，主要市场覆盖北美与欧洲，同时拥有多款针对未满足公共卫生需求的在研产品。
RMR集团是总部位于美国的另类资产管理企业，核心业务聚焦不动产及相关投资，覆盖商业地产、住宅物业、基础设施等赛道，服务全球核心市场的机构投资者、高净值人士及零售客户。
DVAX vs RMR — 直观对比
营收规模更大
DVAX
是对方的1.4倍
$66.7M
营收增速更快
RMR
高出23.1%
17.7%
净利率更高
DVAX
高出10.1%
18.3%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $94.9M | $66.7M |
| 净利润 | $26.9M | $12.2M |
| 毛利率 | — | — |
| 营业利润率 | 22.4% | 48.1% |
| 净利率 | 28.4% | 18.3% |
| 营收同比 | 17.7% | 40.8% |
| 净利润同比 | 53.0% | 91.1% |
| 每股收益（稀释后） | $0.21 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DVAXRMR
| Q4 25 | — | $66.7M | ||
| Q3 25 | $94.9M | — | ||
| Q2 25 | $95.4M | — | ||
| Q1 25 | $68.2M | — | ||
| Q4 24 | $72.0M | — | ||
| Q3 24 | $80.6M | — | ||
| Q2 24 | $73.8M | — | ||
| Q1 24 | $50.8M | — |
净利润DVAXRMR
| Q4 25 | — | $12.2M | ||
| Q3 25 | $26.9M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $-96.1M | — | ||
| Q4 24 | $7.0M | — | ||
| Q3 24 | $17.6M | — | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $-8.7M | — |
营业利润率DVAXRMR
| Q4 25 | — | 48.1% | ||
| Q3 25 | 22.4% | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | -34.7% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 12.5% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | -35.0% | — |
净利率DVAXRMR
| Q4 25 | — | 18.3% | ||
| Q3 25 | 28.4% | — | ||
| Q2 25 | 19.6% | — | ||
| Q1 25 | -141.0% | — | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 15.4% | — | ||
| Q1 24 | -17.2% | — |
每股收益（稀释后）DVAXRMR
| Q4 25 | — | $0.71 | ||
| Q3 25 | $0.21 | — | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | $-0.77 | — | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $49.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $534.1M | $232.7M |
| 总资产 | $946.5M | $687.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DVAXRMR
| Q4 25 | — | $49.3M | ||
| Q3 25 | $160.2M | — | ||
| Q2 25 | $99.1M | — | ||
| Q1 25 | $51.7M | — | ||
| Q4 24 | $95.9M | — | ||
| Q3 24 | $119.3M | — | ||
| Q2 24 | $112.5M | — | ||
| Q1 24 | $132.0M | — |
股东权益DVAXRMR
| Q4 25 | — | $232.7M | ||
| Q3 25 | $534.1M | — | ||
| Q2 25 | $494.2M | — | ||
| Q1 25 | $530.9M | — | ||
| Q4 24 | $596.8M | — | ||
| Q3 24 | $681.4M | — | ||
| Q2 24 | $642.8M | — | ||
| Q1 24 | $618.5M | — |
总资产DVAXRMR
| Q4 25 | — | $687.1M | ||
| Q3 25 | $946.5M | — | ||
| Q2 25 | $918.4M | — | ||
| Q1 25 | $945.9M | — | ||
| Q4 24 | $986.3M | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $986.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | — |
| 自由现金流率自由现金流/营收 | 34.4% | — |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 1.26× | 0.88× |
| 过去12个月自由现金流最近4个季度 | $80.5M | — |
8季度趋势，按日历期对齐
经营现金流DVAXRMR
| Q4 25 | — | $10.7M | ||
| Q3 25 | $33.8M | — | ||
| Q2 25 | $23.4M | — | ||
| Q1 25 | $-19.6M | — | ||
| Q4 24 | $53.0M | — | ||
| Q3 24 | $19.5M | — | ||
| Q2 24 | $10.7M | — | ||
| Q1 24 | $-16.7M | — |
自由现金流DVAXRMR
| Q4 25 | — | — | ||
| Q3 25 | $32.6M | — | ||
| Q2 25 | $22.0M | — | ||
| Q1 25 | $-23.6M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $18.1M | — | ||
| Q2 24 | $9.9M | — | ||
| Q1 24 | $-17.4M | — |
自由现金流率DVAXRMR
| Q4 25 | — | — | ||
| Q3 25 | 34.4% | — | ||
| Q2 25 | 23.0% | — | ||
| Q1 25 | -34.6% | — | ||
| Q4 24 | 68.8% | — | ||
| Q3 24 | 22.5% | — | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | -34.3% | — |
资本支出强度DVAXRMR
| Q4 25 | — | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.5% | — |
现金转化率DVAXRMR
| Q4 25 | — | 0.88× | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
